CALLIDITAS THERAPEUTICS AB's ticker is CALT and the CUSIP is 13124Q106. A total of 14 filers reported holding CALLIDITAS THERAPEUTICS AB in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,835,000 | -78.6% | 62,306 | -80.0% | 0.08% | -73.8% |
| Q1 2021 | $8,574,000 | -18.0% | 311,030 | 0.0% | 0.30% | -35.5% |
| Q4 2020 | $10,457,000 | -24.9% | 311,030 | -46.4% | 0.47% | -41.9% |
| Q3 2020 | $13,920,000 | +3.4% | 580,000 | 0.0% | 0.80% | -16.7% |
| Q2 2020 | $13,456,000 | – | 580,000 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 144,393 | $4,252,000 | 1.17% |
| BVF INC/IL | 750,000 | $22,080,000 | 0.83% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 15,890 | $468,000 | 0.24% |
| Vivo Capital, LLC | 62,306 | $1,835,000 | 0.08% |
| Pentwater Capital Management LP | 50,000 | $1,473,000 | 0.01% |
| NEXT Financial Group, Inc | 4,458 | $131,000 | 0.01% |
| Advisory Services Network, LLC | 3,369 | $99,000 | 0.00% |
| DEUTSCHE BANK AG\ | 71,531 | $2,107,000 | 0.00% |
| JANE STREET GROUP, LLC | 7,216 | $211,000 | 0.00% |
| UBS Group AG | 11 | $0 | 0.00% |